{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:20:36Z","timestamp":1787721636706,"version":"build-2784847793"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Plasmablastic lymphoma is a rare, highly aggressive mature B-cell lymphoma with terminal B-cell\/plasma-cell differentiation. It usually arises in the oral cavity in patients with human immunodeficiency virus infection or other forms of immunodeficiency, whereas primary sinonasal involvement in an apparently immunocompetent patient is uncommon. On hematoxylin-and-eosin examination, it may histomorphologically resemble poorly differentiated epithelial, melanocytic, and other hematolymphoid malignancies, necessitating a broad immunohistochemical panel for definitive diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 75-year-old woman presented with a 1-month history of progressive left-sided nasal obstruction and watery nasal discharge, one episode of epistaxis 12 days before presentation, and reduced olfaction. She had no history of human immunodeficiency virus infection, organ transplantation, or systemic immunosuppression. Anterior rhinoscopy showed a mass occupying the left nasal cavity. Contrast-enhanced computed tomography demonstrated a heterogeneously enhancing, locally destructive soft-tissue lesion occupying the left maxillary sinus with extension into the left ethmoid and frontal sinuses and left nasal cavity, with erosion of the lamina papyracea and maxillary sinus walls. Biopsy showed a high-grade malignant round-cell\/plasmablastic neoplasm with extensive necrosis. The main morphologic differentials included sinonasal undifferentiated carcinoma, non-keratinizing squamous cell carcinoma, amelanotic melanoma, non-Hodgkin lymphoma, and a plasma-cell neoplasm. Immunohistochemistry showed strong, diffuse expression of CD38, CD138, and MUM1; strong but focal nuclear PAX5 expression; focal leukocyte common antigen and Epstein\u2013Barr virus positivity; kappa light-chain restriction; and a Ki-67 proliferation index of 98%\u221299%. Tumor cells were negative for CD20, pancytokeratin, AE1\/AE3, S100, human herpesvirus 8, and lambda light chain. A final diagnosis of plasmablastic lymphoma was rendered. The patient received CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone) and had completed three cycles at 21-day intervals by the 5-month follow-up, with reduced nasal obstruction and overall symptomatic improvement. Post-treatment imaging was unavailable; therefore, radiological and metabolic response could not be assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the need to include plasmablastic lymphoma in the differential diagnosis of an aggressive unilateral sinonasal mass, even in a human immunodeficiency virus-negative elderly patient, and emphasizes the decisive role of a broad immunohistochemical panel with light-chain assessment in resolving morphologic overlap with other high-grade sinonasal malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1925274","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:45:53Z","timestamp":1787719553000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Sinonasal plasmablastic lymphoma in a human immunodeficiency virus-negative elderly woman diagnosed by immunohistochemistry"],"prefix":"10.3389","volume":"13","author":[{"given":"Savitri M.","family":"Nerune","sequence":"first","affiliation":[{"name":"Department of Pathology, Shri B. M. Patil Medical College Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura","place":["Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayandeep K.","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shri B. M. Patil Medical College Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura","place":["Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivshankar","family":"Ajur","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Shri B. M. Patil Medical College Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura","place":["Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishan","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shri B. M. Patil Medical College Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura","place":["Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1354604","DOI":"10.3389\/fimmu.2024.1354604","article-title":"Plasmablastic lymphoma: current knowledge and future directions","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1055\/a-2444-3438","article-title":"Sinonasal plasmablastic lymphoma: a systematic review","volume":"85","author":"Chen","year":"2024","journal-title":"J Neurol Surg Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14744\/nci.2017.57984","article-title":"Single-sided sinonasal mass: a retrospective study","volume":"5","author":"Belli","year":"2018","journal-title":"North Clin Istanb."},{"key":"B8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/2193-1801-2-142","article-title":"Plasmablastic lymphoma of the maxillary sinus in an HIV-negative patient: a case report and literature review","volume":"2","author":"Saraceni","year":"2013","journal-title":"Springerplus"},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5222\/MMJ.2020.45389","article-title":"Nasal plasmablastic lymphoma in an HIV-negative immunocompetent patient","volume":"35","author":"Shakri","year":"2020","journal-title":"Medeni Med J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3324\/haematol.2009.016113","article-title":"Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype","volume":"95","author":"Montes-Moreno","year":"2010","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3324\/haematol.2016.141978","article-title":"Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients","volume":"101","author":"Laurent","year":"2016","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/annonc\/mdw684","article-title":"Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group","volume":"28","author":"Tchernonog","year":"2017","journal-title":"Ann Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/ajh.25955","article-title":"Survival analysis in treated plasmablastic lymphoma patients: a population-based study","volume":"95","author":"Florindez","year":"2020","journal-title":"Am J Hematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bjh.15156","article-title":"Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma","volume":"184","author":"Castillo","year":"2019","journal-title":"Br J Haematol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1925274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:46:15Z","timestamp":1787719575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1925274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":16,"alternative-id":["10.3389\/fmed.2026.1925274"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1925274","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1925274"}}